Comments*

 
  • Academy Events

  • Inositol Phospholipid Signaling

    June 26 - 27, 2012

    Organizers: William G. Kerr (SUNY Upstate Medical University), Christina Mitchell (Monash University, Australia), Christian Rommel (Intellikine)
    Keynote Speaker: Lewis C. Cantley (Harvard Medical School)
    Speakers: Augustin Amour (GlaxoSmithKline), Jens C. Brüning (University of Cologne, Germany), David Chernoff (Aquinox Pharmaceuticals), Wai-Ping Fung-Leung (Johnson & Johnson Pharmaceuticals), Eric C. Holland (Memorial Sloan-Kettering Cancer Center), William G. Kerr (SUNY Upstate Medical University), Thomas Look (Dana Farber Cancer Center), Langdon Miller (Gilead Sciences), Christina Mitchell (Monash University, Australia), Klaus Okkenhaug (Babraham Institute, UK), Vito Palombella (Infinity Pharmaceuticals), Robert C. Rickert (Sanford-Burnham Medical Research Institute), Neal Rosen (Memorial Sloan-Kettering Cancer Center), David B. Solit (Memorial Sloan-Kettering Cancer Center), Laurence Turka (Beth Israel Deaconess Medical Center), Bart Vanhaesebroeck (The Bart's Cancer Institute, UK), Matthias P. Wymann (University of Basel, Switzerland)

    Explore the role of Inositol Phospholipid signaling in cancer, metabolic, and inflammatory disease with the goal of identifying novel approaches for therapeutic intervention.

    Plan Ahead

  • All Events 

    Topics:









    Browse Events from:
    to  

    Location:

    Wednesday, May 30, 2012 | 8:30 AM - 6:30 PM

    Implications of A Data-Driven Built Environment

    Organizers: Chris Garvin (Terrapin Bright Green), Michel Wahome (The New York Academy of Sciences)

    Our intent is to look at the potential data pool for the entire real estate industry and draw out the value between data sets and determine what data we should be collecting in order achieve sustainability and market transformation goals.

    May 31 - June 1, 2012

    Global Capacity Building in Nutrition Science: Training Future Practitioners, Empowering Future Leaders

    Organizer: Mandana Arabi (The Sackler Institute for Nutrition Science)
    Speakers: Gayle Binney (The Dannon Company, Inc.), Glenn Denning (Columbia University), Jessica L. Escobar-Alegria (University of South Carolina), Shibani Ghosh (Tufts University), Robert J. Karp (SUNY-Downstate Medical Center), Nabeeha Kazi (Humanitas Global Development), Pamela A. Koch (Teachers College Columbia University), Hunter Reed (f.a.s.t. nyc), Christina M. Stark (CornellNutritionWorks), Emorn Wasantwisut (Mahidol University), Debra J. Wolgemuth (Columbia University Medical Center), Derek Yach (PepsiCo)

    With rising levels of nutrition-related health issues, this conference will review the state of professional training in the nutrition domain and discuss challenges facing the next generation of scientists, program implementers and policy-makers.

    Monday, June 4, 2012 | 2:00 PM - 7:00 PM

    Genome Integrity Discussion Group Meeting

    Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
    Keynote Speaker: Susan M. Gasser (Friedrich Miescher Institute for Biomedical Research)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, June 5, 2012 | 7:00 PM - 8:30 PM

    The Science Behind the Hype: Resveratrol in Wine & Chocolate

    Speakers: Joseph Baur (University of Pennsylvania) and Nick Venditti (Frankly Wines)

    You may have heard claims about the amazing health benefits of the chemical resveratrol, present in such things as red wine and dark chocolate. But scientific research in this area is in it's infancy. Join us as we talk about the science behind this important chemical compound. We'll also give the science a taste—everyone attending will get to sample local red wine and chocolate.

    Wednesday, June 6, 2012 | 1:00 PM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Organizers: Elizabeth Boon (Stony Brook University), Anthony A. Sauve (Weill Cornell Medical College), Jennifer S. Henry (The New York Academy of Sciences)
    Keynote speaker: Tom W. Muir (Princeton University)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest ideas in this rapidly growing field, and provides a forum for lively discussion and collaboration.

    June 11 - 12, 2012

    Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Pre-Term Birth

    Organizers: Sudhansu K. Dey (Cincinnati Children's Hospital Medical Center), Susan J. Fisher (University of California, San Francisco), and Jeffrey A. Whitsett (Cincinnati Children's Hospital Medical Center)
    Keynote Speakers: Frederick Vom Saal (University of Missouri–Columbia) and Randy L. Jirtle (Duke University)

    This 1.5-day conference will explore recent discoveries, challenges, and future research directions for understanding the complex gene–gene and gene–environment interactions responsible for fetal programming in utero and pre-term birth and the lasting adverse health effects.

    June 15 - 16, 2012

    Imaging Neurodegeneration and Repair in Multiple Sclerosis

    Organizers: Daniel Pelletier (Yale University School of Medicine), Daniel S. Reich (National Institute of Neurological Disorders and Stroke)

    Explore new brain and nerve imaging methods to monitor disease progress and treatment outcomes in Multiple Sclerosis patients.

    Thursday, June 21, 2012 | 11:30 AM - 3:00 PM

    Lyceum Society: Prions

    Speaker: Arline Cohn

    The Lyceum Society is comprised of the Academy's retired and semi-retired members. Talks cover various scientific fields. All Academy members are welcome.

    June 26 - 27, 2012

    Inositol Phospholipid Signaling in Physiology and Disease

    Organizers: William G. Kerr (SUNY Upstate Medical University), Christina Mitchell (Monash University, Australia), Christian Rommel (Intellikine)
    Keynote Speaker: Lewis C. Cantley (Harvard Medical School)
    Speakers: Augustin Amour (GlaxoSmithKline), Jens C. Brüning (University of Cologne, Germany), David Chernoff (Aquinox Pharmaceuticals), Wai-Ping Fung-Leung (Johnson & Johnson Pharmaceuticals), Eric C. Holland (Memorial Sloan-Kettering Cancer Center), William G. Kerr (SUNY Upstate Medical University), Thomas Look (Dana Farber Cancer Center), Langdon Miller (Gilead Sciences), Christina Mitchell (Monash University, Australia), Klaus Okkenhaug (Babraham Institute, UK), Vito Palombella (Infinity Pharmaceuticals), Robert C. Rickert (Sanford-Burnham Medical Research Institute), Neal Rosen (Memorial Sloan-Kettering Cancer Center), David B. Solit (Memorial Sloan-Kettering Cancer Center), Laurence Turka (Beth Israel Deaconess Medical Center), Bart Vanhaesebroeck (The Bart's Cancer Institute, UK), Matthias P. Wymann (University of Basel, Switzerland)

    Examine the role of Inositol Phospholipid (IP) signaling in cancer, metabolic, and inflammatory disease. This exploration of the specificity and interplay of diverse IP-modifying enzymes aims to identify novel approaches for therapeutic intervention.

    Tuesday, June 26, 2012 | 6:30 PM - 8:00 PM

    The Science of Local Food

    Moderator: Robert LaValva (New Amsterdam Market)
    Speakers: Brian Halweil (Editor, Edible Brooklyn), Peter Hoffman (Chef/Owner, Savoy & Back Forty), Robert LaValva (New Amsterdam Market), Jennifer G. Phillips (Bard Center for Environmental Policy)

    From improved nutrition to better environmental stewardship, local food systems have been offered as a panacea for much of what ails us. Join us for a panel discussion, with experts from across the local food community, on the intersection of the science and culture of local food. There will be a tasting after the discussion.

    August 23 - 25, 2012

    Cracking the Neural Code: Third Annual Aspen Brain Forum

    Keynote Speakers: Drs. Christof Koch and Allan Jones (The Allen Institute), David Van Essen (Washington University in St. Louis), and Sean Hill (Ecole Polytechnique Federale de Lausanne)

    This meeting will bring together researchers working at the forefront of systems and computational neuroscience to discuss cutting-edge developments in understanding neural coding from the micro, meso, and macro scale.

    Tuesday, September 25, 2012 | 8:30 AM - 6:00 PM

    Autophagy as a Therapeutic Target in Multiple Diseases: From Molecular Mechanisms to Drug Discovery

    Organizers: Zdenek Berger (Pfizer), Mercedes Beyna (Pfizer), Warren Hirst (Pfizer), Jennifer Henry (The New York Academy of Sciences)
    Speakers: Zdenek Berger (Pfizer), Ana Maria Cuervo (Albert Einstein College of Medicine), Daniel J. Klionsky (University of Michigan), Beth Levine (University of Texas Southwestern Medical Center), Ralph A. Nixon (Nathan Kline Institute), Eileen P. White (Rutgers University), Richard J. Youle (NINDS), Zhenyu Yue (Mount Sinai School of Medicine)

    Autophagy is a route for degradation of aggregated cellular proteins and dysfunctional organelles. This symposium reviews molecular mechanisms of impairment, and discusses drug discovery strategies for modulating autophagy for therapeutic benefits.

    Tuesday, October 23, 2012 | 8:30 AM - 5:00 PM

    The New Age of Antibody Therapeutics

    Organizers: Robert Martone (Covance Biomarker Center of Excellence), Heather Shih (Pfizer External Research Solutions), Mohammad Tabrizi (Merck Research Laboratory), Jennifer Henry, PhD, The New York Academy of Sciences
    Speakers: Anthony Coyle (Pfizer), Peter Kiener (Zyngenia), Serge Muyldermans (Vrijie Universiteit Brussel, Belgium), Carl Nathan (Weill Cornell Medical College), Mohammad Tabrizi (Merck Research Laboratory), K. Dane Wittrup (Massachusetts Institute of Technology), Anna Wu (University of California, Los Angeles)

    There are many monoclonal antibody therapeutics on the market, and myriad development candidates. We review the application of cutting-edge technologies to the development of next-generation antibody therapeutics and address translational challenges.